Phase 3 Atrial Fibrillation New Onset Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 3
Short Term Anti-aRrhythmic Therapy for Post-Operative AF in Cardiac Surgery Patients Pilot Trial
Atrial Fibrillation New Onset
Population Health Research Institute400 enrolled1 locationNCT05841056
Recruiting
Phase 2Phase 3
EMPA-ESUS. a Randomised Control Trial to Investigate the Impact of Empagliflozin on Left Atrial Function in Patients with Embolic Stroke of Undetermined Source
Embolic Stroke of Undetermined SourceAtrial Fibrillation New Onset
University of East Anglia100 enrolled1 locationNCT06715449
Recruiting
Phase 3
MAGNAM Trial, Magnesium Versus Amiodarone in Atrial Fibrillation in Critical Care
Atrial Fibrillation New Onset
Sunnybrook Health Sciences Centre200 enrolled5 locationsNCT05287191